STERIS plc

STE

IE00BFY8C754

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 16:00:02 2024-06-04 EDT			5-day change	1st Jan Change
228.5 ^USD	+0.06%		+2.29%	+3.93%

05-20	Steris Insider Sold Shares Worth $267,313, According to a Recent SEC Filing	MT
05-17	Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing	MT

STERIS plc Appoints Paul E. Martin as Compliance and Technology Committee and the Compensation and Organization Development Committee of the Board

August 02, 2021 at 04:37 pm

On July 29, 2021, Paul E. Martin was appointed to serve on the Compliance and Technology Committee and the Compensation and Organization Development Committee of the Board of STERIS plc.

Latest news about STERIS plc

Steris Insider Sold Shares Worth $267,313, According to a Recent SEC Filing	05-20	MT
Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing	05-17	MT
Steris Insider Sold Shares Worth $475,300, According to a Recent SEC Filing	05-17	MT
Steris Insider Sold Shares Worth $707,850, According to a Recent SEC Filing	05-16	MT
Steris Insider Sold Shares Worth $476,093, According to a Recent SEC Filing	05-16	MT
Servizi Italia renounces acquisition of Steris business unit	05-16	AN
Wolfe Research Adjusts Price Target on STERIS to $240 From $235	05-10	MT
Piper Sandler Adjusts Price Target on STERIS to $225 From $220	05-10	MT
KeyBanc Adjusts Price Target on STERIS to $255 From $253	05-10	MT
Transcript : STERIS plc, Q4 2024 Earnings Call, May 09, 2024	05-09
Steris Fiscal Q4 Non-GAAP EPS, Revenue Rise; Fiscal 2025 Outlook Set -- Share Rise After Hours	05-08	MT
STERIS plc Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-08	CI
STERIS plc Reports Earnings Results for the Full Year Ended March 31, 2024	05-08	CI
STERIS plc Provides Earnings Guidance for the Fiscal Year 2025	05-08	CI
STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024	05-01	CI
Wolfe Research Adjusts STERIS Price Target to $235 From $245	04-19	MT
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	04-11	MT
STERIS to Sell Dental Business to Peak Rock Capital for $787.5 Million in Equity Transaction	04-11	MT
Peak Rock Capital LLC entered into a definitive agreement to acquire Dental segment of STERIS plc for $800 million.	04-10	CI
Integra Testing Services, LLC acquired Controlled Environment Certification Services business of STERIS plc.	03-31	CI
Transcript : STERIS plc, Q3 2024 Earnings Call, Feb 08, 2024	02-08
Steris beats third-quarter estimates on strong medical procedure demand	02-07	RE
Steris Fiscal Q3 Earnings, Revenue Increase; Fiscal 2024 Guidance Revised	02-07	MT
STERIS plc Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-07	CI
STERIS plc Revises Financial Guidance for the Fiscal Year 2024	02-07	CI

STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-11 - Ex-dividend day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for STERIS plc

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

228.5 USD

Average target price

241.9 USD

Spread / Average Target

+5.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
STERIS PLC	+3.93%	22.59B
ABBOTT LABORATORIES	-6.03%	179B
MEDTRONIC PLC	+1.08%	108B
BECTON, DICKINSON AND COMPANY	-2.19%	69.03B
DEXCOM, INC.	-5.98%	45.83B
CENCORA, INC.	+12.31%	45.39B
HOYA CORPORATION	+7.77%	43.17B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.98%	29.89B
TERUMO CORPORATION	+14.45%	25.49B
WEST PHARMACEUTICAL SERVICES, INC.	-9.57%	23.95B

Other Medical Equipment, Supplies & Distribution

STERIS plc

Equities

STE

IE00BFY8C754

Medical Equipment, Supplies & Distribution

STERIS plc Appoints Paul E. Martin as Compliance and Technology Committee and the Compensation and Organization Development Committee of the Board

Latest news about STERIS plc

Chart STERIS plc

Company Profile

Income Statement Evolution

Ratings for STERIS plc

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution